Is Alfacalcidol registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 6 valid registrations of Alfacalcidol, including Alfacalcidol (1 µg, Capsule, soft, SAR 124.90); Alfacalcidol (0.25 µg, Capsule, soft, SAR 47.70); ONE-ALPHA 2MCG-ML AMP. (2 µg, Injection, SAR 103.35); ONE-ALPHA CAPS 0.25 MICROGM (0.25 µg, Capsule, SAR 68.10); ONE-ALPHA CAPS 1.0 MICROGM (1 µg, Capsule, SAR 178.40).

Active substance

Alfacalcidol

SFDA 7
Health Canada 6
NHS prices 5

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Alfacalcidol	1 µg	Capsule, soft · Oral use	100 Blister	SAR 124.90	Generic · Prescription	SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES	Valid
Alfacalcidol	0.25 µg	Capsule, soft · Oral use	100 Blister	SAR 47.70	Generic · Prescription	SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES	Valid
ONE-ALPHA 2MCG-ML AMP.	2 µg	Injection · Intravenous use	10 Ampoule	SAR 103.35	NCE · Prescription	CHEPLAPHARM Arzneimittel GmbH	Valid
ONE-ALPHA CAPS 0.25 MICROGM	0.25 µg	Capsule · Oral use	100 Blister	SAR 68.10	Generic · Prescription	CHEPLAPHARM Arzneimittel GmbH	Valid
ONE-ALPHA CAPS 1.0 MICROGM	1 µg	Capsule · Oral use	100 Blister	SAR 178.40	NCE · Prescription	CHEPLAPHARM Arzneimittel GmbH	Valid
ONE-ALPHA DROPS 2MICROGRAM-ML	2 µ/ml	Oral drops, solution · Oral use	1 Dropper Container	SAR 81.70	NCE · Prescription	CHEPLAPHARM Arzneimittel GmbH	Valid
ONE-ALPHA CAPS 0.25 MICROGM	0.25 µg	Capsule · Oral use	30 Blister	SAR 28.70	Generic · Prescription	Leo Pharma	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDERS; HYPERPARATHYRODISM; VITAMIN D DEFICIENCY

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
ONE-ALPHA	00474517	0.25 MCG	CAPSULE · ORAL	CHEPLAPHARM ARZNEIMITTEL GMBH
ONE-ALPHA	00474525	1 MCG	CAPSULE · ORAL	CHEPLAPHARM ARZNEIMITTEL GMBH
ONE-ALPHA	02240329	2 MCG / ML	DROPS · ORAL	CHEPLAPHARM ARZNEIMITTEL GMBH
ONE-ALPHA	02242502	2 MCG / ML	SOLUTION · INTRAVENOUS	CHEPLAPHARM ARZNEIMITTEL GMBH
SANDOZ ALFACALCIDOL	02533316	0.25 MCG	CAPSULE · ORAL	SANDOZ CANADA INCORPORATED
SANDOZ ALFACALCIDOL	02533324	1 MCG	CAPSULE · ORAL	SANDOZ CANADA INCORPORATED

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
NHS Drug Tariff	Alfacalcidol 1microgram capsules	£8.75	30 capsule	1 Oct 2026
NHS Drug Tariff	Alfacalcidol 250nanogram capsules	£1.77	30 capsule	1 Oct 2026
NHS Drug Tariff	Alfacalcidol 2micrograms/1ml solution for injection ampoules	£41.13	10 ampoule	1 Oct 2026
NHS Drug Tariff	Alfacalcidol 2micrograms/ml oral drops sugar free	£21.30	10 ml	1 Oct 2026
NHS Drug Tariff	Alfacalcidol 500nanogram capsules	£3.31	30 capsule	1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.